The treatment, approved in January, is the first generic of Advair to hit the market. It will be priced between $93.71 and $153.14.
The FDA didn’t approve Advair generics from Novartis and Hikma Pharmaceuticals.
More articles on pharmacy:
Better pharmacy access sought for rural Colorado residents
Following its rival, Sanofi and Regeneron slash price of cholesterol drug by 60%
Mount Carmel’s chief pharmacy officer out amid overprescribing scandal
